Tenecteplase, which was approved by the FDA last June, is also longer acting and specifically targets blood clots, rather than indiscriminately thinning the blood.

• Tenecteplase在 2000年6月得到fda批准使用。 此药作用时间较长，能特异地作用于血栓，而不是不加选择地稀释血液。